# ClinicalTrials.gov record NCT00170157

> PeptideScanner retained ClinicalTrials.gov record NCT00170157 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-05-15, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct00170157-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2017-05-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00170157-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00170157-leuprolide-v1.json
- Content SHA-256: `fcb6f6c2c398627bb70e7c56062817444f5549e395f71ac534f88f528ec3a8c9`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00170157 ([`ctg-observation-nct00170157-2017-05-15-699cb48e8061`](#source-ctg-observation-nct00170157-2017-05-15-699cb48e8061))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00170157 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-05-15, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00170157-2017-05-15-699cb48e8061`](#source-ctg-observation-nct00170157-2017-05-15-699cb48e8061))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00170157 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-05-15, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00170157-2017-05-15-699cb48e8061`](#source-ctg-observation-nct00170157-2017-05-15-699cb48e8061))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00170157-2017-05-15-699cb48e8061`](#source-ctg-observation-nct00170157-2017-05-15-699cb48e8061))

## Sources

<a id="source-ctg-observation-nct00170157-2017-05-15-699cb48e8061"></a>
- **ClinicalTrials.gov record NCT00170157 · retained source version 2017-05-15:699cb48e806146ff2f92251dd2a41d06b5c00f6faf50ae271159c636faaf1dcf** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00170157) (`ctg-observation-nct00170157-2017-05-15-699cb48e8061`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00170157." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00170157-leuprolide-v1.json SHA-256: fcb6f6c2c398627bb70e7c56062817444f5549e395f71ac534f88f528ec3a8c9.